Metraipolis › archive › dc_d77e920002e7

Combined XPO1 Inhibition and Parthenolide Treatment Can Be Efficacious in Treating Triple-Negative Breast Cancer — Europe PMC PMID:41155531

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155531
DOI
10.3390/ijms262010243
License (as archived)
solo-consultazione
Archived
2026-11-09T04:09:46.619Z
SHA-256 of the archived text
54b588fa96fd6a9322630f07111ee43b5af6a0ebf768cc2775c2ee50f7674252
Stable URL of this page
https://metraipolis.com/documento/dc_d77e920002e7

How to cite

Combined XPO1 Inhibition and Parthenolide Treatment Can Be Efficacious in Treating Triple-Negative Breast Cancer — Europe PMC PMID:41155531 — Europe PMC (en), https://europepmc.org/article/MED/41155531 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d77e920002e7 (Metraipolis archive dc_d77e920002e7, sha256 54b588fa96fd6a9322630f07111ee43b5af6a0ebf768cc2775c2ee50f7674252)
BibTeX
@misc{dcd77e920002e7,
  title = {Combined XPO1 Inhibition and Parthenolide Treatment Can Be Efficacious in Treating Triple-Negative Breast Cancer — Europe PMC PMID:41155531},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155531},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d77e920002e7; sha256 54b588fa96fd6a9322630f07111ee43b5af6a0ebf768cc2775c2ee50f7674252},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155531. Agents can read the archived copy with the MCP tool read_document.